1. Winkelmann RK, Förström L: New observations in the histopathology of erythema nodosum. J Invest Dermatol 65:441, 1975
2. Patterson JW: Panniculitis. New findings in the “third compartement”. Arch Dermatol 123:1615, 1987
3. Requena L: Normal subcutaneous fat, necrosis of adipocytes and classification of the panniculitides. Semin Cutan Med Surg 26:66, 2007
4. Thurber S, Kohler S: Histopathologic spectrum of erythema nodosum. J Cutan Pathol 33:18, 2006
5. Fantuzzi G: Adipose tissue, adipokines and inflammation. J Allergy Clin Immunol 115:911, 2005
6. Rolff J, Silva-Jothy MT: Invertebrate ecological immunology. Science 301:472, 2003
7. Ferrandon D et al: The Drosophila systemic immune response: Sensing and signaling during bacterial and fungal infections. Nat Rev Immunol 7:862, 2007
8. Berg AH, Scherer PE: Adipose tissue, inflammation and cardiovascular disease. Circ Res 96:939, 2005
9. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 197:197, 2002
10. Schaffler A, Schölmerich J, Salzberger B: Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28(9):393, 2007
11. Iwasaki A, Medzhitov R: Regulation of adaptive immunity by the innate immune system. Science 327:291, 2010
12. Kanneganti TD, Lamkanfi M, Núnňez G: Intracellular NOD-like receptors in host defense and disease. Immunity 27:549, 2007
13. Miller LS: Toll-like receptors in skin. Adv Dermatol 21:71, 2008
14. Tilg H, Moschen AR: Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6:772, 2006
15. Weisberg SP et al: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796, 2003
16. Curat CA et al: From blood monocytes to adipose tissue-resident macrophages: Induction of diapedesis by human mature adipocytes. Diabetes 53:1285, 2004
17. Nishimura S, Manabe I, Nagai R: Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 8(41):55, 2009
18. Patsouris D et al: Glucocorticoids and thiazolidinediones interfere with adipocyte-mediated macrophage chemotaxis and recruitment. J Biol Chem 284:31223, 2009
19. Kopp A et al: Innate immunity and adipocyte function: Ligand-specific activation of multiple toll-like receptors modulate cytokine, adipokine, and chemokine secretion in adipocytes. Obesity 17:648, 2009
20. Casper-Bauguil S et al: Adipose tissue as an ancestral immune organ: Site specific changes in obesity. FEBS Lett 579:3487, 2005
21. Nishimura S et al: CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8):914, 2009
22. Poggi M et al: The inflammatory receptor CD40 is expressed on human adipocytes: Contribution to crosstalk between lymphocytes and adipocytes. Diabetologia 52(6):1152, 2009
23. Rajsheker S et al: Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol 10:1, 2009. Doi:10.1016/j.coph.2009,11.005
24. Chatterjee TK et al: Proinflammatory phenotype of perivascular adipocytes: Influence of high fat feeding. Circ Res 104:541, 2009
25. Gesta S, Tseng YH, Kahn CR: Developmental origin of fat: Tracking obesity to its source. Cell 131:242, 2007
26. Cypess AM et al: Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509, 2009
27. Requena L, Sanchez Yus E: Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dematol 45:163, 2001
28. Requena L, Requena C: Erythema nodosum. Dermatol Online J 8(1):4, 2002
29. Garcia-Porruũa C et al: Erythema nodosum. Arthritis Rheum 43(3):584, 2000
30. Cribier B et al: Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 37:667, 1998
31. Kunz M, Beutel S, Brocker E: Leukocyte activation in erythema nodosum. Clin Exp Dermatol 24:396, 1992
32. Llorente L et al: Elevated Th1 cytokine mRNA in skin biopsies and peripheral circulation in patients with erythema nodosum. Eur Cytokine Netw 8:67, 1997
33. Senturk T et al: Adhesion molecules expression in erythema nodosum like lesions in Behcets disease. A histopathological and immunhistochemical study. Rheumatol Int 18:51, 1998
34. Labunski S et al: Tumor necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 81:18, 2001
35. Amoli MM et al: Macrophage migration inhibitory factor gene polymorphism in associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 29(8):1671, 2002
36. Amoli MM et al: Regulated upon activation normal T cell expressed and secreted (RANTES) and epithelial derived neutrophil-activating peptide (EM-78) genopolymorphism in patients with biopsy proven erythema nodosum. Clin Exp Rheumatol 27(1 suppl 52):S142, 2009
37. Schäffler A et al: Role of adipose tissue as an inflammatory organ in human diseases. Endocrinol Rev 27(5):449, 2006
38. Braverman IM: Protective effects of erythema nodosum in coccidiomycoses. Lancet 353:168, 1999
39. Grunewald J, Eklund A: Löfgren's syndrome. Human leukocyte antigen strongly influences the disease course. Am J Resp Crit Care Med 179:307, 2009
40. Candore G et al: Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: A genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 57(7):274, 2003
41. White WL, Hitchcock MG: Diagnosis: Erythema nodosum or not? Semin Cutan Med Surg 18(1):47, 1999
42. Requena L, Sanchez Yus E: Erythema nodosum. Semin Cutan Med Surg 26:114, 2007
43. Kakourou T et al: Erythema Nodosum in children: A prospective study. J Am Acad Dermatol 44:17, 2001
44. Chopra R et al: Panniculitis: Clinical overlap and the significance of biopsy findings. J Cutan Pathol 37:49, 2010
45. Forstrom J, Winkelmann RK: Acute Panniculitis: A clinical and histopathological study of 34 cases. Arch Dermatol 183:909, 1977
46. Mert A et al: Erythema nodosum: An evaluation of 100 cases. Clin Exp Rheumatol 25(4):563, 2007
47. Sterling JB, Heymann WR: Potassium iodide in dermatology: A 19th century drug for the 21st century – uses pharmacology, adverse effects, and contraindications. J Am Acad Dermatol 43:691, 2000
48. Davatchi F et al:
Colchicine versus placebo in Behcets disease: A randomized, double blind controlled crossover trial.
Mod Rheumatol 19(5):542, 2009
49. Boyd AS: Etancercept treatment of erythema nodosum. Skinmed 6(4):197, 2007
50. Hanauer SB: How do I treat erythema nodosum, apthous ulcerations and pyoderma gangrenosum? Inflamm Bowel Dis 4:78, 1998
51. Mascaró JM Jr, Baselga E: Erythema induratum of Bazin. Dermatol Clin 26:439, 2008
52. Segura S et al: Vasculitis in erythema induratum of Bazin: A histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol 59:839, 2008
53. Requena L, Sanchez Yus E: Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 45: 325, 2001
54. Patterson JW: Panniculitis. In: Dermatology, vol. 2, 2nd edition, edited by JL Bolognia, JL Jorizzo, RP Rapini. Spain, Mosby Elsevier, 2008, pp. 1515-1535. Chapter 100
55. James WD, Berger TG, Elston DM, eds: Vessel based lobular panniculitis In: Andrews' Diseases of The Skin: Clinical Dermatology, 10th edition. Canada, WB Saunders Elsevier, 2005, p. 489.
56. Degitz K et al: Successful treatment of erythema induratum of Bazin following rapid detection of mycobacterial DNA by polymerase chain reaction. Arch Dermatol 129:1619, 1993
57. Chuang YH et al: Simultaneous occurrence of papulonecrotic tuberculid and erythema induratum and the identification of Mycobacterium tuberculosis DNA by polymerase chain reaction. Br J Dermatol 137:276, 1997
58. Baselga E et al: Detection of MTB DNA in lobular granulomatous panniculitis (erythema induratum-nodular vasculitis). Arch Dermatol 133:457, 1997
59. Gimenez-Garcia R et al: Red fingers syndrome and recurrent panniculitis in a patient with chronic hepatitis C. J Eur Acad Dermatol Venereol 17:692, 2003
60. Fernandez SS et al: Erythema induratum and chronic hepatitis C infection. J Clin Virol 2009. Doi:10.1016/j.jcv.2008.12.019
61. Pozdnyakova O, Garg A, Mahalingam M: Nodular vasculitis—A novel cutaneous manifestation of autoimmune colitis. J Cutan Pathol 35:315, 2008
62. Patterson JW, Brown PC, Broecker AH: Infection-induced panniculitis. J Cutan Pathol 16:183, 1989
63. Wolf D et al: Nodular vasculitis associated with
propylthiouracil therapy.
Cutis 49:253, 1992
64. Ollert MW, Thomas P, Korting HC: Erythema induratum of Bazin. Evidence of T-lymphocyte hyperresponsiveness to purified protein derivative of tuberculin: Report of two cases and treatment. Arch Dermatol 129:469, 1993
65. Angus J, Robers C, Kulkarni K: Usefulness of the QuantiFERON™ test in the confirmation of latent tuberculosis in association with erythema induratum. Br J Dermatol 157:1267, 2007
66. Lighter J et al: Erythema induratum of Bazin in a child: Evidence for a cell-mediated hyperresponse to Mycobacterium tuberculosis. Pediatr Infect Dis J 28:326, 2009
67. Neyrolles O et al: Is adipose tissue a place of Mycobacterium Tuberculosis persistence? PLoSOne 1(1):e43 Doi:10.1371/journal.pone.0000043
68. Bouwman JJM et al. Infection—Induced inflammatory response of adipocytes in vitro. Int J Obes 32:892, 2008
69. Bechah Y et al: Adipose tissue serves as a reservoir for recrudescent rickettsia prowazekii infection in a mouse model. PLoS One 5(1):e8547, 2010. Doi:10.1371/journal.pone.0008547
70. Nagajyothi F et al: Chagas disease, adipose tissue and the metabolic syndrome. Mem Inst Oswaldo Cruz 104(Suppl. 1):219, 2009
71. Nagajyothi F et al: Trypanosoma cruzi infection of cultured adipocytes result in an inflammatory phenotype. Obesity 16(9):1992, 2008
72. Varghese S et al: Association between membranous glomerulonephritis and erythema induratum (Nodular vasculitis)—A case report. Indian J Nephrol 12:27, 2002
73. Silva MTT et al: Distal painful peripheral neuropathy associated with erythema induratum of Bazin. Eur J Neurol 13:e5, 2006
74. Shaffer N, Kerdel FA: Nodular vasculitis (erythema induratum): Treatment with
auranofin.
J Am Acad Dermatol 25:426, 1991
75. Taverna JA et al: Case report: Nodular vasculitis response to
mycophenolate mofetil.
J Drugs Dermatol 5:992, 2006
76. Jorizzo J et al: Sclerosing panniculitis: A clinicopathologic assessment. Arch Dermatol 127:554-558, 1991
77. Kirsner R et al: The clinical spectrum of lipodermatosclerosis. J Am Acad Dermatol 28:623, 1993
78. Bruce AJ et al: Lipodermatosclerosis: Review of cases evaluated at Mayo Clinic. J Am Acad Dermatol 46:187, 2002
79. Kahle B et al: Tightening tight junction with compression therapy. J Invest Dermatol 121(5):1228, 2003
80. Herouy Y et al: Tight junctions and compression therapy in chronic venous insufficiency. Int J Mol Med 18:215, 2006
81. Leu A et al: Morphology of chronic venous insufficiency—Light and electron microscopic examination. Vasa 20:330, 1991
82. Falanga V, Bontempo FA, Eagelstein WH: Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulcers. Arch Dermatol 126:1195, 1990
83. Schmeller W, Roszinski S, Huesmann M: Tissue oxygenation and microcirculation in dermatoliposclerosis with different degrees of erythema at the margin of venous ulcers: A contribution to hypodermitis symptoms. Vasa 26:18, 1997
84. Saharay M et al: Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 26:265, 1997
85. Peschen M et al: Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 290:291, 1998
86. Pappas P et al: Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. J Vasc Surg 30:1129, 1999
87. de Giorgo-Miller A et al: Procollagen type I gene expression and cell proliferation are increased in lipodermatoslerosis. Br J Dermatol 152:242, 2005
88. Ye J et al: Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 293:E1118, 2007
89. Halberg N, Wernstedt I, Scherer PE: The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 37(3):753, 2008. Doi:10.1016/j.ecl.2008.07.002.
90. Halberg N et al: Hypoxia—Inducible factor 1α induces fibrosis and
insulin resistance in white adipose tissue.
Mol Cell Biol 29(16):4467, 2009. Doi:10.1128/MCB.00192-09
91. Khan T et al: Metabolic dysregulation and adipose tissue fibrosis: Role of
collagen VI.
Mol Cell Biol 29(6):1575, 2009
92. Cantwell A, Kelso DW, Rowe L: Hypodermitis sclerodermformis and unusual acid fast bacteria. Arch Dermatol 115(4):449, 1979
93. Greenberg A et al: Acute lipodermatosclerosis is associated with venous insufficiency. J Am Acad Dermatol 35:566, 1996
94. Jinnin M et al: Sclerosing panniculitis is associated with pulmonary hypertension is systemic sclerosis. Br J Dermatol 153:579, 2005
95. Huang TM, Lee JYY: Lipodermatosclerosis: A clinicopathologic study of 17 cases and differential diagnosis from erythema nodosum. J Cutan Pathol 36:453, 2009
96. Diaz-Cascajo C, Borghi S: Subcutaneous pseudomembranous fat necrosis: New observations. J Cutan Pathol 29:5, 2002
97. Allegre
VA, Winkelmann RK, Aliaga A: Lipomembranous changes in chronic panniculitis.
J Am Acad Dermatol 19:39, 1988
98. Weedon D, ed: Panniculitis. In: Weedon's Skin Pathology. Churchill Livingstone Elsevier, Elsevier, London, 2010, p. 472
99. Gniadecka M, Karlsmark T, Bertram A: Removal of dermal edema with class I and II compression stockings in patients with lipodermatosclerosis. J Am Acad Dermatol 39:966, 1998
100. Dakovic' Z et al: Acute lipodermatosclerosis: An open clinical trial of stanazolol in patients unable to sustain compression therapy. Dermatol Online J 14(2):1, 2008
101. Segal S, Cooper J, Bolognia J: Treatment of lipodermatosclerosis with
oxandrolone in a patient with stanazolol induced hepatotoxicity.
J Am Acad Dermatol 43(3):558, 2000
102. Hafner C et al: Lipodermatosclerosis: Successful treatment with
Danazol.
Acta Derm Venereol 85:365, 2005
103. Jull A et al:
Pentoxifylline for treating venous leg ulcers.
Cochrane Database Syst Rev 18(3):CD001733, 2007
104. Pittler MH, Ernst E: Horse chestnut seed extract for chronic venous insufficiency: A criteria— Based systematic review. Arch Dermatol 134(11):1356, 1998
105. Pittler MH, Ernst E: Horse Chesnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2:CD003230, 2004
106. Petruzzellis V et al: Oxerutins (Venoruton): Efficacy in chronic venous insufficiency—A doube-blind, randomized controlled study. Angiology 53(3):257, 2002
107. Cesarone MR et al: Venoruton vs Daflon: Evaluation of effects on quality of life in chronic venous insufficiency. Angiology 57(2):131, 2006
108. Gohel MS, Davies AH: Pharmacological agents in the treatment of venous disease: An update of available evidence. Curr Vasc Pharmacol 7(3):303, 2009
109. Rowe L, Cantwell AR Jr: Hypodermitis sclerodermiformis: Successful treatment with ultrasound. Arch Dermatol 118(5):312, 1982
110. Damian DL et al: Ultrasound therapy for lipodermatosclerosis. Arch Dermatol 145(3):330, 2009
111. Delgado-Jimenez Y, Fraga J, Garcia-Diez A: Infective panniculitis. Dermatol Clin 26:471, 2008
112. Spalding SJ et al: Staphyococcus aureus panniculitis complicating juvenile dermatomyositis. Pediatrics 119:e530, 2007. Doi:10.1542/peds.2006-1518
113. Chen WS et al: Mycobacterium associated lobular panniculitis, mimicking a rheumatoid nodule in a patient with rheumatoid arthritis. J Formos Med Assoc 108:673, 2009
114. Bourre-Tessier J et al: Disseminated Histoplasma capsulatum infection presenting with panniculitis and focal myositis in rheumatoid arthritis treated with
etanercept.
Scan J Rheumatol 14:1, 2009
115. Zhang CZ, Fung MA, Eisen DB: Disseminated fusariosis presenting as panniculitis like lesions on the legs of a neutropenic girl with acute lymphblastic leukemia. Dermatol Online J 15(10):5, 2009
116. Leber JH et al: Distinct TLR-and NLR mediated transcriptional response to an intracellular pathogen. PLoS Pathog 4(1):e6, 2008. Doi 10.1371/journal.ppat.0040006
117. Sirard JC et al: Nod-Like receptors: Cytosolic watchdogs for immunity against pathogens. PLoS Pathog 3(2):e152, 2007. doi:10.1371/journal.ppat.0030152
118. Combs TP et al: The adipocyte an an important target cell for Trypansoma cruzi infection. J Biol Chem 280:24085, 2005
119. Hazan UIA et al: Human adipose cells express CD4, CXCR4 and CCR5 receptors: A new target for immunedeficiency virus-1. FASEB J 16:1254, 2002
120. Maurin T et al: Tumor necrosis factor alpha stimulates HIV-1 production in primary cultures of human adipocytes. Exp Cell Res 304:544, 2005
121. Desruisseaux MS et al: Adipocyte, adipose tissue and infectious disease: Minireview. Infect Immunol 75(3):1066, 2007. Doi:10.1128/IAI.01455-06
122. Schneider JW et al: Erythema induratum of Bazin. A clinicopathologic study of 20 cases and detection of Mycobacterium tuberculosis DNA in skin lesion by polymerase chain reaction. Am J Dermatopathol 17:350, 1995
123. Godard CM: Mycobacterium leprae: Behavior in the adipocyte undergoing differentiation. C R Acad Sci III 316:1355, 1993. French
124. Godard CM: Attempts to cultivate Mycobacterium leprae in fat tissue. Acta Leprol 8:133, 1998.
125. Pamer EG: TLR polymorphism and the risk of invasive fungal infections. N Engl J Med 359:17, 2008
126. Kang T-J, Chae, G-T: Detection of Toll-like receptor 2(TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31:53, 2001
127. Arbour NC et al: TLR-4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187, 2000
128. Bochud P-Y et al: Toll-like receptor 4 polymorphism and aspergillosis in stem cell transplantation. N Engl J Med 359:1766, 2008
129. Morrison LK et al: Infections and panniculitis. Dermatol Ther 23(4):328-340, 2010
130. Bartralot R, Garcia-Patos V, Sitjas D: Clinical patterns of cutaneous nontuberculous mycobacteria infections. Br J Dermatol 152:727, 2005
131. Kutzner H et al: A new application of
BCG antibody for rapid screening of various tissue microorganisms.
J Am Acad Dermatol 38:56, 1998
132. Ballestero-Diez M et al: Septal panniculitis associated with cytomegalovirus infection. Histopathology 46(6):720, 2005
133. Pottage JC et al: Panniculitis associated with Histoplasmosis and alpha-1-antitrypsin deficiency. Am J Med 75:150, 1983
134. Kambott MI: Review article: Biochemical and genetic aspects of human serum alpha-1 proteinase inhibitor protein. Dis Markers 3(3-4):135, 1985
135. Perlmutter DH et al: The cellular defect in 1 proteinase inhibitor deficiency is expressed in human monocytes and xonopus oocytes injected with human liver mRNA. Proc Natl Acad Sci U S A 82:6918, 1985
136. Andersen MM: Leucocyte associated plasma proteins. Scand J Clin Lab Invest 43:49, 1983
137. Van Furth R, Kramps JS, Diessel hof de Dalk MM: Synthesis of alpha-1-antitrypsin by human monocytes. Clin Exp Immunol 51:551, 1983
138. Breit SN et al: Immunoregulation by alpha-1-antitrypsin. J Clin Lab Immunol 7:127, 1982
139. Breit SN et al. The role of alpha-1-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 35:363, 1985.
140. Lipsky JJ et al: Presence of alpha-1-antitrypsin on mitogen stimulated human lymphocytes. J Immunol 122:24, 1979
141. Ades EW et al: Modulation of the immune response by plasma protein inhibitors. Scan J Immunol 15:109, 1982
142. Stoller JK, Aboussouan LS: α1-antitrypsin deficiency. Lancet 365:2225, 2005
143. Gross B et al: New Findings in PiZZ α-1-antitrypsin deficiency related panniculitis. Dermatology 2008. DOI:10.1159/000202982
144. Silverman EK, Sandhaus RA: Alpha-1-Antitrypsin deficiency. N Engl J Med 360:2749, 2009
145. Loche F et al: Panniculitis revealing qualitative alpha-1-antitrypsin deficiency MS variant. Eur J Dermatol 9:565, 1999
146. Geraminejad P et al: Alpha-1-antitrypsin associated panniculitis: The MS variant. J Am Acad Dermatol 51:645, 2004
147. Stoller JK, Piliang M: Panniculitis in alpha-1-antitrypsin deficiency. Clin Pulm Med 15:113, 2008
148. Pittelkow MR, Smith KC, Su WPD: Alpha-1-antitrypsin deficiency and panniculitis. Am J Med 84(Suppl. 6A):80, 1988
149. Smith KC et al: Clinical and pathological correlations in 96 patients with panniculitis, including 15 patients with deficient levels of α1-antitrypsin. J Am Acad Dermatol 21:1192, 1989
150. Chng WJ, Henderson CA: Suppurative panniculitis associated with alpha-1-antitrypsin deficiency (PiSZ phenotype) treated with doxycyline. Br J Dermatol 144:1262, 2001
151. Rubinstein HM et al: Alpha-1-antitrypsin deficiency with severe panniculitis. Report of two cases. Ann Intern Med 86:742, 1977
152. Balk E et al: Alpha-1-antitrypsin deficiency with vascular leakage syndrome and panniculitis. Neth J Med 25:138, 1982
153. Eng AM, Aronson IK: Dermatopathology of panniculitis. Semin Dermatol 3(1):1, 1984
154. Kobbe P et al: The role of fracture associated soft tissue injury in the induction of systemic inflammation and remote organ dysfunction after bilateral femur fracture. J Orthop Trauma 22(6):385, 2008
155. Boden G et al: Acute tissue injury caused by subcutaneous biopsies produce endoplasmic reticulum stress. J Clin Endocrinol Metab 95(1):349, 2010
156. Geller JD, Su WPD: A subtle clue to the histopathologic diagnoses of early alpha-1-antitrypsin deficiency panniculitis. J Am Acad Dermatol 31:241, 1994
157. Su WPD et al: Alpha-1-antitrypsin deficiency panniculitis: A histopathologic and immunopathologic study of four cases. Am J Dermatopathol 9:483, 1987
158. Hendrick SJ et al: Alpha-1-antitrypsin associated with panniculitis. J Am Acad Dermatol 18:684, 1988.
159. Smith KC, Pittelkow MR, Su WPD: Panniculitis associated with severe α1-antitrypsin deficiency. Arch Dermatol 123:1655, 1987
160. Sutra-Loubet C et al: Neutrophilic panniculitis. J Am Acad Dermatol 50:280, 2004
161. Dyer JA et al: Neutrophilic panniculitis in infancy: A cutaneous manifestation of juvenile rheumatoid arthritis. J Am Acad Dermatol 57(5):S65, 2007
162. Breit SN et al: Familial occurrence of α1-antitrypsin deficiency and Weber Christian Disease. Arch Dermatol 119:198, 1983
163. Bleumink E, Klokke HA: Protease—Inhibitor deficiencies in a patient with Weber Christian Panniculitis. Arch Dermatol 120 936, 1984
164. Ortiz PG, Skov BG, Benfeldt E: α1-antitrypsin deficiency associated panniculitis: Case report and review of treatment options. J Eur Acad Dermatol Venereol 19:487, 2005
165. Humbert P et al: Use of anti-collagenase properties of doxycyline in treatment of alpha-1-antitrypsin deficiency panniculitis. Acta Derm Venereol (Stockh) 71:189, 1991
166. Viraben R et al: Necrotic panniculitis with alpha-1-antitrypsin deficiency. J Am Acad Dermatol 14(4):684, 1986
167. Furey NL, Golden RS, Potts SR: Treatment of alpha-1-antitrypsin deficiency, massive edema and panniculitis with alpha-1-protease inhibitor. Ann Intern Med 128(8):699, 1996
168. O'Riordan K et al: Alpha-1-antitrypsin deficiency associated panniculitis: Resolution with intravenous alpha-1-antitrypsin administration and liver transplantation. Transplantation 63(3):480, 1997
169. Fernandez-Torres R et al: Alpha-1-antitrypsin deficiency panniculitis acquired after liver transplant and successfully treated with retransplant. J Am Acad Dermatol 60(4):715, 2009
170. Dahl PR et al: Pancreatic panniculitis. J Am Acad Dermatol 33:413, 1995
171. Lopez A et al: Pancreatitis associated with pleural mediastinal pseudocyst, panniculitis and polyarthritis. Clin Rheumatol 17:335, 1998
172. Cutlan RT et al: A fatal case of pancreatic panniculitis presenting in a young patient with systemic lupus. J Cutan Pathol 27:466, 2000
173. Hughes SH, Apisarnthanarax P, Mullins F: Subcutaneous fat necrosis associated with pancreatic disease. Arch Dermatol 111:506, 1975
175. Narváez J et al: Pancreatitis, panniculitis and polyarthritis. Semin Arthritis Rheum 39(5):417-423, 2010
176. Echeverria CM et al: Pancreatic pannicultis in a kidney transplant recipient. Int J Dermatol 40:751, 2001
177. Pike JL et al: Pancreatic Panniculitis associated with allograft pancreatitis and rejection in a simultaneous Pancreas-Kidney Transplant Recipient. Am J Transplant 6:2502, 2006
178. Breuer GS et al: Lupus—Associated panreatitis. Autoimmun Rev 5(5):314, 2006
179. Abdallah M et al: Acute pancreatitis associated with hemophagocytic syndrome in systemic lupus erythematosus: A case report. Gastroenterol Clin Biol 10:1054, 2005
180. Cairoli E et al: Fatal acute pancreatitis complicated by pancreatic pseudocysts in a patient with systemic lupus erythematosus. Rheumatol Int 30(5):675-678, 2010 [Epub May 23, 2009]
181. Potts DE, Mass MF, Iseman MD: Syndrome of pancreatic disease, subcutaneous fat necrosis and polyserositis. Am J Med 58:417, 1975
182. Wilson JA, Askari AD, Neiderhiser DH: Pancreatitis with arthropathy and subcutaneous fat necrosis. Arthritis Rheum 26:121, 1983
183. Berman B et al: Fatal pancreatitis presenting with subcutaneous fat necrosis. J Am Acad Dermatol 17:359, 1987
184. Schäffler A et al: Potential of adipcytokines in predicting peripancreatic necrosis and severity in acute pancreatitis: Pilot study. J Gastroenterol Hepatol 22:326, 2007
185. Sanchez MH, Fernandez RS, Bomez Calcerrada MR: Single nodule pancreatic panniculitis. Dermatology 193:269, 1996
186. Beltraminelli HS, Beuchner SA, Hausermann P: Pancreatic Panniculitis in a paitent with an acinar cell cystadenocarcinoma of the pancreas. Dermatology 208:265, 2004
187. Ball NJ et al: Possible origin of pancreatic fat necrosis as a septal panniculitis. J Am Acad Dermatol 34:362, 1996
188. Ball NJ, Cowan BJ, Hashimoto SA: Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases. J Cutan Pathol 36(3):331, 2009
189. Heykarts B, Anseeuw M, Degreef H: Panniculitis caused by acinous pancreatic carcinoma. Dermatology 198:182, 1999
190. Hudson-Peacock MJ, Regnard CFB, Farr PM: Liquefying panniculitis associated with acinous carcinoma o the pancreas responding to ocreotide. J R Soc Med 87:361, 1994
191. Francombe J, Kingsnorth AN, Tunn E: Panniculitis arthritis and pancreatitis. Br J Rheumatol 34:680, 1995
192. Tuffanelli DL: Lupus erythematosus panniculitis (profundus): Clinical and immunologic studies. Arch Dermatol 103:231, 1971
193. Winkelmann RK: Panniculitis in connective tissue diseases. Arch Dermatol 119:336, 1983
194. Fraga J, García-Díez A: Lupus erythematosus panniculitis. Dermatol Clin 26:453, 2008
195. Arai S. Katsuoka K: Clinical entity of Lupus Erythematosus panniculitis/lupus erythematosus profundus. Autoimmun Rev 8:449, 2009
196. Massone C et al: Lupus erythematosus panniculitis (lupus profundus): Clinical, histopathological and molecular analysis of nine cases. J Cutan Pathol 32:396, 2005
197. Martens PB, Moder KG, Ahmed I: Lupus panniculitis: Clinical perspective from a case series. J Rheumatol 26:68, 1999
198. Nitta Y: Lupus erythematosus profundus associated with neonatal lupus erythematosus. Br J Dermatol 136:112, 1997
199. Kopp A et al: Innate immunity and adipocyte function: Ligand-specific activation of multiple Toll-like receptors modulate cytokine, adipokine and chemokine secretion in adipocytes. Obesity 17:648, 2009
200. Wenzel J et al: Type 1 interferon associated cytotoxic inflammation in cutaneous lupus erythematosus. Arch Dermatol Res 301:83, 2009.
201. Marshak-Rothstein A: Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6:823, 2006
202. Lafyatis R, Marshak-Rothstein A: Toll like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res Ther 9:222, 2007
203. Barrat FJ, Coffman RL: Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol Rev 223:271, 2008
204. Santiago-Raber ML, Baudino L, Izui S: Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun 33:231, 2009
205. Kono DH et al: Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A 106:12061, 2009
206. Kim WU, Sreih A, Bucala R: Toll-like receptors in systemic lupus erythematosus: Prospects for therapeutic intervention. Autoimmun Rev 8(3):204, 2009
207. Tao K et al: Genetic variations of Toll-like receptor 9 predisposes to systemic lupus erythematosus in Japanese population. Ann Rheum Dis 66:905, 2007
208. Visentini M et al: Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency. Arthritis Rheum 60:2767, 2009
209. Drexler SK, Foxwell BM: The roll of toll-like receptors in chronic inflammation. Int J Biochem Cell Biol 42:506, 2010
210. Lafyatis R, York M, Marshak-Rothstein A: Anti-malarial agents: Closing the gate on Toll-like receptors. Arthritis Rheum 54(10):3068, 2006
211. Nowinski T et al: Ocular involvement in lupus erythematosus profundus (Panniculitis). Ophthalmology 89:1149, 1982
212. Magee KL et al: Lupus Erythematosus profundus with periorbital swelling and proptosis. J Am Acad Dermatol 24(2):288, 1991
213. Nousari HC, Kimyai-Asadi A, Provost TT: Generalized lupus erythematosus profundus in a patient with partial deficiency of C4. J Am Acad Dermatol 41:362, 1999
214. Magro CM et al: Lupus Profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: A spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol 28:235, 2001
215. Wang C-YE, Su WPD, Kurtin PJ: Subcutaneous panniculitic T-cell lymphoma (review). Int J Dermatol 35:1, 1996
216. Willemze R, Jansen PM, Cerroni L: Subcutaneous panniculitis—Like Tcell lymphoma: Definition classification, and prognostic factors: An EORTC Cutaneous Lymphoma Study Group Study of 83 cases. Blood 111:838, 2008
217. Aguilera P et al: Cutaneous γδ T cell lymphoma: A histopathologic mimicker of lupus erythematosus profundus. (lupus pannicultis). J Am Acad Dermatol 56:643, 2007
218. Ma L, Bandarchi B, Glusac EJ: Fatal subcutaneous panniculitis-like T cell lymphoma with interface changes and dermal mucin, a dead ringer for lupus erythematosus. J Cutan Pathol 32:360, 2005
219. Cassis TB, Fearneyhough PK, Callen JP: Subcutaneous panniculitis—Like T-cell lymphoma with vacuolar interface dermatitis resembling lupus erythematosus panniculitis. J Am Acad Dermatol 50:465, 2004
220. Mori Y et al: A case of systemic lupus erythematosus with hemophagocytic syndrome and cytophagic panniculitis. Ryumachi 41(1):31, 2001
221. James WD, Berger TG, Elston DM: Lupus erythematosus panniculitis. In: Andrews' Diseases of The Skin : Clinical Dermatology, 10th edition. Canada, WB Saunders Elsevier, 2005, p. 159
222. Wenzel J et al: CXCR3- mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundus. J Am Acad Dermatol 56:648, 2007.
223. Hansen C, Callen J: Connective tissue panniculitis. Dermatol Ther 23(4):341-349, 2010
224. Callen JP: Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 16:245, 2002
225. Chung HS, Hann SK: Lupus panniculitis treated by a combination therapy of
hydroxychloroquine and quinacrine.
J Dermatol 24:569, 1997
226. Rahman P, Gladman DD, Urowitz MB: Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25:1716, 1998
227. Jewell ML, McCauliffe DP: Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42:983, 2000
228. Kreuter A et al: Lupus Erythematosus tumidus: Response to antimalarial treatment in 36 patients with emphasis on smoking. Arch Dermatol 145(3):244, 2009
229. Wozniacka A et al: The influence of antimalarial treatment on IL-1β, IL-6 and TNF-α mRNA expression on UVB-iradiated skin in systemic lupus erythematosus. Br J Dermatol 159:1124, 2008
230. Guillaume S, Lerebours E: Toll-like receptor-4 signaling: A possible candidate pathway to support tobacco smoking effects in ulcerative colitis. Am J Gastroenterol 103:2947, 2008
231. Mortaz E et al: Cigarette smaoke attenuates the production of cytokines by human plasmacytodid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respir Res 10:47, 2009
232. Requena L, Sanchez Yus E, Kutzner H: Panniculitis. In: Fitzpatrick Dermatology in General Medicine, 7th edition, edited by K Wolff, LA Goldsmith, SI Katz, BA Gilchrest, A Paller, DJ Leffel. New York, McGraw Hill Medical, 2008, p. 583, Chapter 68
233. Ujiie H et al: Lupus erythematosus profundus successfully treated with
dapsone: Review of the literature.
Arch Dermatol 142:399, 2006
234. Atra E, Sato EI: Treatment of cutaneous lesions of systemic lupus erythematosus with
thalidomide.
Clin Exp Rheumatol 11:487, 1993
235. Sacki Y et al: Maintaining remission of lupus erythematosus profundus (LEP) with
cyclosporine A.
Lupus 9:390, 2000
236. Espirito Santo J et al. Intravenous immunoglobulin in lupus panniculitis. Clin Rev Allergy Immunol 2009. DOI 10.1007/s12016-8162-x
237. McCardle A, Baker JF: A case of “refractory” lupus erythematosus profundus responsive to
rituximab (case report).
Clin Rheumatol 28:745, 2009
238. Janis JF, Winkelmann RK: Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases. Arch Dermatol 97:640, 1968
239. Douvoyiannis M et al: Panniculitis, infection and dermatomyositis: Case and literature review Clin Rheumatol 28(S1):S57, 2009.
240. Solans R et al: Panniculitis: A cutaneous manifestation of dermatomyositis. J Am Acad Dermatol 46:S148, 2002
241. Hemmi S et al: Magnetic resonance imaging diagnosis of panniculitis in dermatomyositis. Muscle Nerve 41:151, 2010
242. Neidenback PJ, Sahn EE, Helton J: Panniculitis in juvenile dermatomyositis 33:305, 1995
243. Molnar K et al: Panniculitis in dermatomyositis: Report of two cases. Br J Dermatol 139:161, 1998.
244. Winkelman W, Billick RC, Srolovitz H: Dermatomyositis presenting as panniculitis. J Am Acad Dermatol 23:127, 1990
245. Ghali FE et al: Panniculitis in juvenile dermatomyositis. Pediatr Dermatol 16(4):270, 1999.
246. Penňate Y et al: Calcinosis cutis associated with amyopathic dermatomyositis: Response to intravenous immunoglobulin. J Am Acad Dermatol 60:1076, 2009
247. Alegre
VA, Winkelmann RK: Histiocytic cytophagic panniculitis.
J Am Acad Dermatol 20:177, 1989
248. Craig AJ et al: Cytophagic histiocytic panniculitis—A syndrome associated with benign and malignant panniculitis: Case comparison and review of the literature. J Am Acad Dermatol 39:721, 1998
249. Chen RL et al: Cytophagic histiocytic panniculitis with fatal hemophagocytic lymphohistiocytosis in a paediatric patient with perforin gene mutation. J Clin Pathol 60:1168, 2007
250. Winkelmann RK, Bowie EJW: Hemorrhagic diathesis associated with benign histiocytic cytophagic panniculitis and systemic histiocytosis. Arch Int Med 140(11):1460, 1980
251. Crotty CP, Winkelmann RK: Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure and terminal hemorrhagic diathesis. J Am Acad Dermatol 4:181, 1981
252. Risdall RJ et al: Virus-associated hemophagocytic syndrome: A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:993, 1979
253. Aronson IK et al: Fatal panniculitis. J Am Acad Dermatol 12(3):535, 1985
254. Aronson IK, Worobec SM: Cytophagic histiocytic panniculitis and hemophagocytic lymphohistiocytosis: An overview. Dermatol Ther 23(4):389-402, 2010
255. Janka G et al. Infection and malignancy associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 12:435, 1998
256. Palazzi DL, McClain KL, Kaplan SL: Hemophagocytic syndrome in children: An important diagnostic consideration in fever of unknown origin. Clin Infect Dis 36:306, 2003
257. Tristano AG: Macrophage activation syndrome: A frequent but underdiagnosed complication associated with rheumatic disease. Med Sci Monit 14(3):RA27, 2008
258. Parodi A et al: Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty eight patients. Arthritis Rheum 60(11):3388, 2009
259. Grom AA: Natural killer cell dysfunction: A common pathway in systemic juvenile rheumatoid arthritis, macrophage activation syndrome and hemophagocytic lymphohistiocytosis. Arthritis Rheum 50(3):689, 2004
260. Gutierrez-Rave Pecero VM et al:
Phenytoin induced hemophagocytic histiocytosis indistinguishable from malignant histiocytosis.
South Med J 84:649, 1991
261. Lurati A et al: Macrophage activation syndrome (MAS) during anti-IL-1 receptor therapy (
anakinra) in a patient affected by systemic onset idiopathic juvenile arthritis (so-JIA): A report and review of the literature.
Pediatr Rheumatol Online J 3(2):79, 2005
262. Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am 28:293, 2008
263. Masters SL et al: Horror autoinflammaticus: The molecular pathophysiology of autoinflammatory disease. Ann Rev Immunol 27:621, 2009
264. Vastert SJ, Kuis W, Grom AA: Systemic JIA: New development in the understanding of the pathophysiology and therapy. Best Pract Res Clin Rheumatol 23:655, 2009
265. Badolato R, Parolini S: Novel insights from adaptor protein 3 complex deficiency. J Allergy Clin Immunol 120:735, 2007
266. Westbroek W et al: Cellular defects in Chediak-Higashi syndrome correlate with the molecular genotype and clinical phenotype. J Invest Dermatol 127:2674, 2007
267. Rigaud S et al: XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444(7115):110, 2006
268. Lowin B et al: A null mutation in the perforin gene impairs cytolytic T lymphocytes and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci U S A 91:11575, 1994
269. Rouphael NG et al: Infection associated with hemophagocytic syndrome. Lancet Infect Dis 7:814, 2007
270. Wick MR, Patterson JW: Cytophagic histiocytic panniculitis—A critical reappraisal. Arch Dermatol 136:922, 2000
271. Marzano AV et al: Cytophagic histiocytic panniculitis and subcutaneous panniculitis T-cell lymphoma. Arch Dermatol 136:889, 2000
272. Schaer DJ et al: Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haemotol 74:6, 2005
273. Requena L, Sanchez Yus E, Kutzner H: Panniculitis. In: Fitzpatrick Dermatology in General Medicine, 7th edition, edited by K Wolff, LA Goldsmith, SI Katz, BA Gilchrest, A Paller, DJ Leffell. New York, McGraw Hill Medical, 2008, p. 583. Chapter 68
274. White JW, Winkelmann RK: Cytophagocytic histiocytic panniculitis is not always fatal. J Cutan Pathol 16:137, 1989
275. Petterson T et al: Cytophagic histiocytic panniculitis: A report of four cases. Br J Dermatol 127:635, 1992
276. Guitart J, Sethi R, Gordon K: Fatal cytophagocytic panniculitis after a short response to
cyclosporine.
J Eur Acad Dermatol Venereol 10:167, 1998
277. Henter JI et al: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124, 2007
278. Behrens EM et al: Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis. J Rheumatol 33(10):2081, 2006
279. Burden AD, Krafchik BR: Subcutaneous fat necrosis of the newborn: A review of 11 cases. Pediatr Dermatol 16:384, 1999
280. Norwood-Galloway A, Lebwohl M, Phelps RG: Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol 16:435, 1987
281. Ladoyanni E et al: Subcutaneous fat necrosis in a newborn associated with asymptomatic and uncomplicated hypercalcemia. Pediatr Dermatol 26(2):217, 2009
282. Tran JT, Sheth AP: Complications of Subcutaneous fat necrosis of the newborn: A case report and review of the literature. Pediatr Dermatol 20:257, 2003
283. Torrelo A, Hernandez A: Panniculitis in children. Dermatol Clin 26:491, 2008
284. Mahé E et al: Subcutaneous fat necrosis of the newborn: A systematic evaluation of risk factors, clinical manifestations, complications and outcome of 16 children. Br J Dermatol 156:709, 2007
286. Diamantis S et al: Subcutaneous fat necrosis in a newborn following icebag application for treatment of supraventricular tachycardia. J Perinatol 26:518, 2006.
287. Carraccio C, Papadimitriou J, Feinberg P: Subcutaneous fat necrosis of the newborn: Link to maternal use of
cocaine during pregnancy.
Clin Pediatr (Phila) 33:317-318, 1994
288. Silverman AK, Michels EH, Rasmussen JE: Subcutaneous fat necrosis in an infant occurring after hypothermic cadiac surgery. J Am Acad Dermatol 15:331, 1986
289. Farooque A et al: Expression of 25 hydroxyvitamin D3–1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol 160:423, 2008
290. Heaton JM: The distribution of brown adipose tissue in the human. J Anat 112:35, 1972
291. Spiegelman B: The skinny fat. The Scientist 29:29-34, 2008
292. deMeis L et al: Fusion of endoplasmic reticulum and mitochondrial outer membrane in rats brown adipose tissue: Activation of thermogenesis by Ca2+. PLoS One 5(3):e9439. Doi:10.1371/journal.pone.0009439
293. Vasireddy S et al: MRI and US findings of subcutaneous fat necrosis of the newborn. Pediatr Radiol 39:73, 2009
294. Balfour E, Antaya RJ, Lazova R: Subcutaneous fat necrosis of the newborn presenting as large plaque with lobulated cystic areas. Cutis 70:169, 2002
295. Tajirian A et al: Subcutaneous fat necrosis of the newborn with eosinophilic granules. J Cutan Pathol 34(7):588, 2007
296. Fretzin F, Arias AM: Sclerema neonatorum and subcutaneous fat necrosis of the newborn. Pediatr Dermatol 4:112, 1987
297. Jaffe N, Hann HWL, Vawter GF: Post-steroid panniculitis in acute leukaemia. N Engl J Med 284:366, 1971
298. Roenigk HH, Haserick JR, Arundell FD: Post-steroid panniculitis; Report of a case and review of literature. Arch Dermatol 90:387, 1964
299. Silverman RA et al: Poststeroid Panniculitis: A case report. Pediatr Dermatol 5:92, 2008
300. Jardine D, Atherthon DJ, Trompeter RS: Sclerema neonatorum and subcutaneous fat necrosis of the new born in the same infant. Eur J Pediatr 150:125, 1990
301. Aucharaz K et al: Treatment of hypercalcemia in subcutaneous fat necrosis is controversial. Horm Res 68:31, 2007
302. Rice AM, Rivkees SA:
Etidronate therapy for hypercalcemia in subcutaneous fat necrosis of the newborn.
J Pediatr 134:349, 1999
303. Vijayakumar M et al: Subcutaneous fat necrosis with hypercalcemia. Indian Pediatr 43:360, 2006
304. Hung SH et al: Oral
clodronate therapy for hypercalcemia related to extensive subcutaneous fat necrosis in a newborn.
J Formos Med Assoc 102(11):801, 2003
305. Alos N et al:
Pamidronate treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.
Horm Res 65:289, 2006
306. Lombet J: Commentary on ‘Padmidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis’ by Alos N. Horm. Res 1006; 65: 289–294. Horm Res 70:254, 2008
307. Epstein EH, Oren ME: Popsicle panniculitis. N Engl J Med 282:966, 1970
308. Quesada-Cortés A et al: Cold panniculitis. Dermatol Clin 26:485, 2008
309. Ter Poorten JC, Hebert AA, Ilkiw R: Cold panniculitis in a neonate. J Am Acad Dermatol 33:383, 1995.
310. Harkness G et al: Ultrasound appearance of scrotal fat necrosis in prepupertal boys. Pediatr Radiol 37:370, 2007
311. Nemoy NJ, Rosin S, Kaplan L: Scrotal panniculitis in the prepubertal male patient. J Urol 118:492, 1977
312. Justrabo E et al: Bilateral scrotal panniculitis in a prebuscent child. Arch Anat Cytol Pathol 46(3):208, 1998
313. Solomon LM, Beerman HB: Cold panniculitis. Arch Dermatol 88:265, 1963.
314. Beacham B et al: Equestrian cold panniculitis in women. Arch Dermatol 116:1025, 1980.
315. DeSilva BD, McLaren K, Doherty VR: Equestrian perniosis associated with cold agglutinins: A novel finding. Clin Exp Dermatol 25:285, 2000
316. Price RD, Murdoch DR: Perniosis (chilbains) of the thigh: Report of five cases including four following river crossings. High Alt Med Biol 2:535, 2001
317. Magnus Fredriksson J, Nikami H, Nedergaard J: Cold-induced expression of the VEGF gene in brown adipose tissue in independent of thermogenic
oxygen consumption.
FEBS Lett 579:5680, 2005
318. Vallerand AL et al: Cold stress increases lipolysis. FR Ra and TG/FFA cycling in humans. Aviat Space Environ Med 70(1):42, 1999
319. Gasparetti AL et al: Cold exposure induces tissue specific modulation of the insulin-signalling pathway in Rattus norvegicus. J Physiol 552(1):149, 2003
320. Lee JS: Factitional panniculitis induced by cupping and acupuncture. Cutis 55(4):217, 1995
321. Winkelmann RK, Barker SM: Factitial traumatic panniculitis. J Am Acad Dermatol 13(6):988, 1985
322. Sanmartin O, Requena C, Requena L: Factitial panniculitis. Dermatol Clin 26:519, 2008